Its massive re sp. Cash flow into ANP would prevent all future dillution, bring us to a new level out of development into early maturity.
you could times an earnings ratio by 50 and still be on the conservative side imo.
Thats all big investors are looking for, funding.... then boom.
- Forums
- ASX - By Stock
- PER
- Ann: Long COVID study identifies diagnostic & therapeutic targets
Ann: Long COVID study identifies diagnostic & therapeutic targets, page-5
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.8¢ |
Change
-0.003(3.70%) |
Mkt cap ! $82.67M |
Open | High | Low | Value | Volume |
8.1¢ | 8.1¢ | 7.8¢ | $215.5K | 2.715M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 137820 | 7.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.0¢ | 319232 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 137820 | 0.078 |
4 | 308042 | 0.077 |
4 | 296000 | 0.076 |
6 | 732416 | 0.075 |
2 | 20313 | 0.074 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 319232 | 3 |
0.081 | 188810 | 1 |
0.082 | 183268 | 1 |
0.083 | 37500 | 1 |
0.085 | 225000 | 1 |
Last trade - 15.59pm 19/11/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |